Literature DB >> 23055879

Optimal treatment of campylobacter dysentery.

Lea S Eiland1, Lauren S Jenkins.   

Abstract

Keywords:  Campylobacter jejuni; diarrhea; hematochezia; infant; macrolides

Year:  2008        PMID： 23055879      PMCID： PMC3462042          DOI： 10.5863/1551-6776-13.3.170

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  12 in total

1.  A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species.

Authors:  Anders Ternhag; Tommi Asikainen; Johan Giesecke; Karl Ekdahl
Journal:  Clin Infect Dis       Date:  2007-01-25       Impact factor: 9.079

2.  The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken.

Authors:  Guillermo M Ruiz-Palacios
Journal:  Clin Infect Dis       Date:  2007-01-25       Impact factor: 9.079

3.  Sporadic campylobacter infection in infants: a population-based surveillance case-control study.

Authors:  Kathleen E Fullerton; L Amanda Ingram; Timothy F Jones; Bridget J Anderson; Patrick V McCarthy; Sharon Hurd; Beletshachew Shiferaw; Duc Vugia; Nicole Haubert; Tameka Hayes; Stephanie Wedel; Elaine Scallan; Olga Henao; Frederick J Angulo
Journal:  Pediatr Infect Dis J       Date:  2007-01       Impact factor: 2.129

4.  Infective dose of Campylobacter jejuni in milk.

Authors:  D A Robinson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

5.  Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

Authors:  K E Smith; J M Besser; C W Hedberg; F T Leano; J B Bender; J H Wicklund; B P Johnson; K A Moore; M T Osterholm
Journal:  N Engl J Med       Date:  1999-05-20       Impact factor: 91.245

6.  Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--10 states, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

Review 7.  Campylobacter jejuni Infections: update on emerging issues and trends.

Authors:  B M Allos
Journal:  Clin Infect Dis       Date:  2001-03-28       Impact factor: 9.079

8.  Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis.

Authors:  B J Anders; B A Lauer; J W Paisley; L B Reller
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

9.  Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children.

Authors:  E Salazar-Lindo; R B Sack; E Chea-Woo; B A Kay; Z A Piscoya; R Leon-Barua; A Yi
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

10.  Treatment of Campylobacter-associated enteritis with erythromycin.

Authors:  R M Robins-Browne; M K Mackenjee; M N Bodasing; H M Coovadia
Journal:  Am J Dis Child       Date:  1983-03
View more
  4 in total

1.  Effect of Danofloxacin Treatment on the Development of Fluoroquinolone Resistance in Campylobacter jejuni in Calves.

Authors:  Debora Brito Goulart; Ashenafi Feyisa Beyi; Zuowei Wu; Mehmet Cemal Adiguzel; Anastasia Schroeder; Kritika Singh; Changyun Xu; Melda Meral Ocal; Renee Dewell; Grant A Dewell; Paul J Plummer; Qijing Zhang; Orhan Sahin
Journal:  Antibiotics (Basel)       Date:  2022-04-15

2.  Comparison of Antimicrobial Susceptibility of Campylobacter Strains Isolated from Food Samples and Patients with Diarrhea.

Authors:  Bita Bakhshi; Amin Naseri; Masoud Alebouyeh
Journal:  Iran Biomed J       Date:  2015-11-25

Review 3.  Non-prescription dispensing of antibiotic agents among community drug retail outlets in Sub-Saharan African countries: a systematic review and meta-analysis.

Authors:  Sewunet Admasu Belachew; Lisa Hall; Linda A Selvey
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-14       Impact factor: 4.887

4.  Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene aac(3)-IV.

Authors:  Michel Plattner; Marina Gysin; Klara Haldimann; Katja Becker; Sven N Hobbie
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.